David Freedman
Listed on 1 Form D filing across 1+ issuer
· Executive Officer
Associated issuers
- Everest Biolabs, Inc. CIK 2116676 · MA
Filings (1)
-
Everest Biolabs, Inc.D · Mar 11, 2026 · MA · Biotechnology$5.7MView filing →